CONSUN PHARMA Publishes 2026 Interim Report and Adopts Full e-Communication Regime

Bulletin Express09-24 06:21

Consun Pharmaceutical Group Limited announced on 24 September 2026 that its Interim Report 2026 is now available in both English and Chinese on the websites of the Hong Kong Stock Exchange (www.hkexnews.hk) and the company (www.chinaconsun.com).

• Electronification of corporate communications – Pursuant to HKEX Listing Rule 2.07A, Consun Pharma is transitioning to electronic dissemination for all future corporate communications, including annual and interim reports, financial statements, circulars, meeting notices and proxy forms. – Printed copies will no longer be dispatched by default.

• Access and request mechanism – Non-registered shareholders holding shares through banks, brokers, custodians, nominees or HKSCC Nominees Limited must provide a functional email address to their intermediaries to receive electronic notifications when new documents are posted. – Shareholders encountering difficulties in accessing online documents—or preferring hard copies—can request printed versions at no cost by emailing consunpharma.ecom@computershare.com.hk or writing to the company’s Hong Kong branch share registrar, Computershare Hong Kong Investor Services Limited, 17M Floor, Hopewell Centre, 183 Queen’s Road East, Wan Chai, Hong Kong.

• Key dates and contacts – Notification date: 24 September 2026. – Enquiries: (852) 2862 8688, Monday–Friday, 9:00 a.m.–6:00 p.m. (HKT).

Chairman An Meng signed the notice on behalf of the Board, underscoring Consun Pharma’s commitment to efficiency and sustainability through digital communication while maintaining the option of free printed materials upon request.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1157846806?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-09-24 06:21","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1157846806","market":"us","top_or_hot":-1,"title":"CONSUN PHARMA Publishes 2026 Interim Report and Adopts Full e-Communication Regime","media":"Bulletin Express","content":"<p>Consun Pharmaceutical Group Limited announced on 24 September 2026 that its Interim Report 2026 is now available in both English and Chinese on the websites of the Hong Kong Stock Exchange (www.hkexnews.hk) and the company (www.chinaconsun.com).</p>\n<p>• Electronification of corporate communications  \n  – Pursuant to HKEX Listing Rule 2.07A, Consun Pharma is transitioning to electronic dissemination for all future corporate communications, including annual and interim reports, financial statements, circulars, meeting notices and proxy forms.  \n  – Printed copies will no longer be dispatched by default.</p>\n<p>• Access and request mechanism  \n  – Non-registered shareholders holding shares through banks, brokers, custodians, nominees or HKSCC Nominees Limited must provide a functional email address to their intermediaries to receive electronic notifications when new documents are posted.  \n  – Shareholders encountering difficulties in accessing online documents—or preferring hard copies—can request printed versions at no cost by emailing consunpharma.ecom@computershare.com.hk or writing to the company’s Hong Kong branch share registrar, Computershare Hong Kong Investor Services Limited, 17M Floor, Hopewell Centre, 183 Queen’s Road East, Wan Chai, Hong Kong.</p>\n<p>• Key dates and contacts  \n  – Notification date: 24 September 2026.  \n  – Enquiries: (852) 2862 8688, Monday–Friday, 9:00 a.m.–6:00 p.m. (HKT).</p>\n<p>Chairman An Meng signed the notice on behalf of the Board, underscoring Consun Pharma’s commitment to efficiency and sustainability through digital communication while maintaining the option of free printed materials upon request.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>CONSUN PHARMA Publishes 2026 Interim Report and Adopts Full e-Communication Regime</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nCONSUN PHARMA Publishes 2026 Interim Report and Adopts Full e-Communication Regime\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-09-24 06:21</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Consun Pharmaceutical Group Limited announced on 24 September 2026 that its Interim Report 2026 is now available in both English and Chinese on the websites of the Hong Kong Stock Exchange (www.hkexnews.hk) and the company (www.chinaconsun.com).</p>\n<p>• Electronification of corporate communications  \n  – Pursuant to HKEX Listing Rule 2.07A, Consun Pharma is transitioning to electronic dissemination for all future corporate communications, including annual and interim reports, financial statements, circulars, meeting notices and proxy forms.  \n  – Printed copies will no longer be dispatched by default.</p>\n<p>• Access and request mechanism  \n  – Non-registered shareholders holding shares through banks, brokers, custodians, nominees or HKSCC Nominees Limited must provide a functional email address to their intermediaries to receive electronic notifications when new documents are posted.  \n  – Shareholders encountering difficulties in accessing online documents—or preferring hard copies—can request printed versions at no cost by emailing consunpharma.ecom@computershare.com.hk or writing to the company’s Hong Kong branch share registrar, Computershare Hong Kong Investor Services Limited, 17M Floor, Hopewell Centre, 183 Queen’s Road East, Wan Chai, Hong Kong.</p>\n<p>• Key dates and contacts  \n  – Notification date: 24 September 2026.  \n  – Enquiries: (852) 2862 8688, Monday–Friday, 9:00 a.m.–6:00 p.m. (HKT).</p>\n<p>Chairman An Meng signed the notice on behalf of the Board, underscoring Consun Pharma’s commitment to efficiency and sustainability through digital communication while maintaining the option of free printed materials upon request.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"01681","symbol_name":"康臣药业","start_time":0,"source_url":"","article_id":"1157846806","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1157846806","pubTimestamp":1790202081,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"Consun Pharmaceutical Group Limited announced on 24 September 2026 that its Interim Report 2026 is now available in both English and Chinese on the websites of the Hong Kong Stock Exchange...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"01681":"康臣药业"},"translate_title":"康生医药发布2026年中期报告并采用全面电子沟通制度","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"01681":1},"content_text":"Consun Pharmaceutical Group Limited announced on 24 September 2026 that its Interim Report 2026 is now available in both English and Chinese on the websites of the Hong Kong Stock Exchange (www.hkexnews.hk) and the company (www.chinaconsun.com).\n• Electronification of corporate communications  \n  – Pursuant to HKEX Listing Rule 2.07A, Consun Pharma is transitioning to electronic dissemination for all future corporate communications, including annual and interim reports, financial statements, circulars, meeting notices and proxy forms.  \n  – Printed copies will no longer be dispatched by default.\n• Access and request mechanism  \n  – Non-registered shareholders holding shares through banks, brokers, custodians, nominees or HKSCC Nominees Limited must provide a functional email address to their intermediaries to receive electronic notifications when new documents are posted.  \n  – Shareholders encountering difficulties in accessing online documents—or preferring hard copies—can request printed versions at no cost by emailing consunpharma.ecom@computershare.com.hk or writing to the company’s Hong Kong branch share registrar, Computershare Hong Kong Investor Services Limited, 17M Floor, Hopewell Centre, 183 Queen’s Road East, Wan Chai, Hong Kong.\n• Key dates and contacts  \n  – Notification date: 24 September 2026.  \n  – Enquiries: (852) 2862 8688, Monday–Friday, 9:00 a.m.–6:00 p.m. (HKT).\nChairman An Meng signed the notice on behalf of the Board, underscoring Consun Pharma’s commitment to efficiency and sustainability through digital communication while maintaining the option of free printed materials upon request.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"0","news_tag":"SGX","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.50.1","shortVersion":"4.50.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1157846806","isCrawlerRequest":true}